Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARBs in COVID-19 Respiratory Disease
NCT04394117Phase 4Completed
- Sponsor
- The George Institute for Global Health
- Start
- Jun 2020
- Primary completion
- Nov 2021
- Countries
- 2
01
Overview
Phase 4, randomised, open-label trial in coronavirus disease 2019 (COVID-19), sponsored by The George Institute for Global Health. Started Jun 2020; status: completed.
02
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04394117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04394117.